Moving beyond Combinatorial Chemistry for Greater Efficiency in Lead Discovery

Pfizer Inc. is a research based global pharmaceutical company committed to the discovery and development of innovative medicines that improve the quality of life of individuals throughout the world. In order to gain a competitive advantage over competitor companies in the discovery of new medicines, we must speed up drug discovery and drive down costs. Using non-combinatorial chemistry techniques increases the efficiency with which we discover new ‘leads,’ leveraging our drug discovery efforts through retaining complete control over the properties of each product made. Compound purification, managed through in-house software, augments the quality of data obtained upon biological screening of compounds.